Does RADIUM RA-223 DICHLORIDE Cause Prostatic specific antigen increased? 449 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 449 reports of Prostatic specific antigen increased have been filed in association with RADIUM RA-223 DICHLORIDE (Xofigo). This represents 9.3% of all adverse event reports for RADIUM RA-223 DICHLORIDE.
449
Reports of Prostatic specific antigen increased with RADIUM RA-223 DICHLORIDE
9.3%
of all RADIUM RA-223 DICHLORIDE reports
58
Deaths
61
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From RADIUM RA-223 DICHLORIDE?
Of the 449 reports, 58 (12.9%) resulted in death, 61 (13.6%) required hospitalization, and 5 (1.1%) were considered life-threatening.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RADIUM RA-223 DICHLORIDE. However, 449 reports have been filed with the FAERS database.
What Other Side Effects Does RADIUM RA-223 DICHLORIDE Cause?
Hormone-refractory prostate cancer (441)
Death (376)
Anaemia (324)
Metastases to bone (315)
General physical health deterioration (308)
Fatigue (242)
Haemoglobin decreased (236)
Prostate cancer (234)
Nausea (221)
Pain (215)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
ABIRATERONE (1,581)
RELUGOLIX (335)
BICALUTAMIDE (322)
DOCETAXEL (282)
APALUTAMIDE (251)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
OLAPARIB (176)
Which RADIUM RA-223 DICHLORIDE Alternatives Have Lower Prostatic specific antigen increased Risk?
RADIUM RA-223 DICHLORIDE vs RALOXIFENE
RADIUM RA-223 DICHLORIDE vs RALTEGRAVIR
RADIUM RA-223 DICHLORIDE vs RALTITREXED
RADIUM RA-223 DICHLORIDE vs RAMELTEON
RADIUM RA-223 DICHLORIDE vs RAMIPRIL